Himalaya-The podcast Player

4.8K Ratings
Open in app
title

Empowered Patient Podcast

Karen Jagoda

1
Followers
3
Plays
Empowered Patient Podcast

Empowered Patient Podcast

Karen Jagoda

1
Followers
3
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

Latest Episodes

Developing Momelotinib to Treat the Cancer Myelofibrosis with Dr. Barbara Klencke Sierra Oncology

Dr. Barbara Klencke, Chief Development Officer, Sierra Oncology talks about the development of momelotinib for myelofibrosis, a rare blood cancer. Momelotinib's unique mechanism of action allows it to address all three key symptoms of myelofibrosis, including the debilitating anemia which can be exacerbated by currently available therapies. The Phase 3 MOMENTUM Clinical Trial evaluating momelotinib for patients with MF is currently recruiting globally. To learn more: momentumtrial.com

18 MIN4 d ago
Comments
Developing Momelotinib to Treat the Cancer Myelofibrosis with Dr. Barbara Klencke Sierra Oncology

Impact of COVID-19 on African American Community with Robert Ferguson DietFreeLife

Robert Ferguson, nutritionist, author, Health Ambassador to StayHealthy, & creator of DietFreeLife talks about the risk factors and pre-existing health inequalities in the African American community that have led to a high rate of infection from COVID-19. Robert is particularly focused on excess body fat and the impact of what we eat on diabetes, cancer and hypertension. He emphasizes the need to be more health conscious and to resist peer pressure, questionable sources of health information and diet fads

16 MIN5 d ago
Comments
Impact of COVID-19 on African American Community with Robert Ferguson DietFreeLife

Breathable Cannabis Addresses Dosing Challenges with Andreas Boeckl Dispersa Labs

Andreas Boeckl, founder, Dispersa Labs is bringing to the market Sula, breathable cannabis, inhaled from measured doses using a device that does not require combustion.This approach to dosing medical cannabis for specific conditions like neurological disorders, stress, anxiety, PTSD, and pain provides much faster relief than edible cannabis and allows for more flexibility for where the cannabis can be administered.Andreas also emphasizes value of this solution for researchers studying use of cannabinoid

17 MIN1 w ago
Comments
Breathable Cannabis Addresses Dosing Challenges with Andreas Boeckl Dispersa Labs

Changing the Physics of Cells Using Nanotechnology to Fight Cancer with Laurent Levy Nanobiotix

Laurent Levy, CEO, Nanobiotix talks about using nanoparticles and nanotechnology to destroy cancer cells by bringing a physics perspective to drug development. The Nanobiotix technology has demonstrated improvement in the efficacy of radiation therapy for patients with soft tissue sarcoma, with an intention to expand across oncology, reducing the side effects and potentially reducing duration of the radiation.

14 MIN1 w ago
Comments
Changing the Physics of Cells Using Nanotechnology to Fight Cancer with Laurent Levy Nanobiotix

Leveraging Advanced Machine Learning to Improve Healthcare with Nancy Hornberger ElectrifAi

Nancy Hornberger, EVP, ElectrifAi, worked with IBM & the Watson Group earlier in her career. She brings deep expertise about data to a company that is using advanced machine learning & artificial intelligence to drive profit improvement, increase performance & reduce risk in the health care industry. We talk about the role of ML & Ai in helping to balance system demands & streamlining processes by reducing mundane work of looking at raw data & images so that clinicians can make better diagnostic decisions.

16 MIN2 w ago
Comments
Leveraging Advanced Machine Learning to Improve Healthcare with Nancy Hornberger ElectrifAi

Treating Central Nervous System and Neural System Diseases by Improving Efficacy of Compounds with Dr. Werner Rein Theranexus

Dr. Werner Rein, Chief Medical Officer, Theranexus shines a light on their evolving understanding of central nervous and neurological system diseases, the discovery of the glial system in the brain and the connection between the glial cells and neurons, and the drive to find compound combinations that can be modulated to treat sleep-wake disorder, cognitive decline and chronic pain.

15 MIN2 w ago
Comments
Treating Central Nervous System and Neural System Diseases by Improving Efficacy of Compounds with Dr. Werner Rein Theranexus

Impact of COVID-19 on Breast Cancer Treatment with Dr. Andrea Madrigrano Surgeon Rush University Medical Center

Dr. Andrea Madrigrano is a general surgeon w/expertise in breast cancer at Rush University Medical Center in Chicago.She shines a light on how hospitals have determined the non-essential surgeries in these times of the COVID virus, how women are dealing w/delayed surgeries related to their breast cancer, alternative therapies that are buying some time for women while they wait for restrictions to lift, & opportunity for research comparing results from current innovations with more traditional approaches.

14 MIN2 w ago
Comments
Impact of COVID-19 on Breast Cancer Treatment with Dr. Andrea Madrigrano Surgeon Rush University Medical Center

Using AI to Identify Combinations of Drugs to Fight COVID-19 with Daniel Cohen Pharnext

Daniel Cohen, Founder, Pharnext discusses how the French biopharma company is using its artificial intelligence (AI) driven platform to identify drugs that have already been approved which can be used in combination to fight COVID-19. Dr. Cohen who lead Pharnext as CEO for over a decade has recently left that role to become Chairman of Pharnext's Scientific Advisory Board in order to focus on his true passion--maximizing the potential of Pharnext's Pleotherapy platform.

16 MIN3 w ago
Comments
Using AI to Identify Combinations of Drugs to Fight COVID-19 with Daniel Cohen Pharnext

Pepinemab Antibody Drug in Development for Neurodegenerative Diseases with Maurice Zauderer Vaccinex

Maurice Zauderer, CEO, Vaccinex discusses pepinemab, the antibody drug being developed by Vaccinex for treatment of Huntington's disease, Alzheimer's disease and lung cancer. Maurice also touches on the relationship between neurodegenerative diseases and cancer, and the commonalities that allow for a treatment like pepinemab to have a potential benefit in both therapeutic areas.

15 MIN3 w ago
Comments
Pepinemab Antibody Drug in Development for Neurodegenerative Diseases with Maurice Zauderer Vaccinex

Why Type 2 Diabetes is a Risk Factor for COVID-19 with Dr. John Poothullil

Dr. John Poothullil is an expert on diabetes and author with many books on the subject of diabetes, cancer, and diet. He shares insights about why type 2 diabetes is considered such a high risk factor for COVID-19 and how the coronavirus attacks the body. He also discusses the challenges of identifying the correct antibodies to fight the disease and provides advice for people with type 2 diabetes as well as everyone else about social distancing, diets and exercise in these stressful times.

16 MINAPR 24
Comments
Why Type 2 Diabetes is a Risk Factor for COVID-19 with Dr. John Poothullil

Latest Episodes

Developing Momelotinib to Treat the Cancer Myelofibrosis with Dr. Barbara Klencke Sierra Oncology

Dr. Barbara Klencke, Chief Development Officer, Sierra Oncology talks about the development of momelotinib for myelofibrosis, a rare blood cancer. Momelotinib's unique mechanism of action allows it to address all three key symptoms of myelofibrosis, including the debilitating anemia which can be exacerbated by currently available therapies. The Phase 3 MOMENTUM Clinical Trial evaluating momelotinib for patients with MF is currently recruiting globally. To learn more: momentumtrial.com

18 MIN4 d ago
Comments
Developing Momelotinib to Treat the Cancer Myelofibrosis with Dr. Barbara Klencke Sierra Oncology

Impact of COVID-19 on African American Community with Robert Ferguson DietFreeLife

Robert Ferguson, nutritionist, author, Health Ambassador to StayHealthy, & creator of DietFreeLife talks about the risk factors and pre-existing health inequalities in the African American community that have led to a high rate of infection from COVID-19. Robert is particularly focused on excess body fat and the impact of what we eat on diabetes, cancer and hypertension. He emphasizes the need to be more health conscious and to resist peer pressure, questionable sources of health information and diet fads

16 MIN5 d ago
Comments
Impact of COVID-19 on African American Community with Robert Ferguson DietFreeLife

Breathable Cannabis Addresses Dosing Challenges with Andreas Boeckl Dispersa Labs

Andreas Boeckl, founder, Dispersa Labs is bringing to the market Sula, breathable cannabis, inhaled from measured doses using a device that does not require combustion.This approach to dosing medical cannabis for specific conditions like neurological disorders, stress, anxiety, PTSD, and pain provides much faster relief than edible cannabis and allows for more flexibility for where the cannabis can be administered.Andreas also emphasizes value of this solution for researchers studying use of cannabinoid

17 MIN1 w ago
Comments
Breathable Cannabis Addresses Dosing Challenges with Andreas Boeckl Dispersa Labs

Changing the Physics of Cells Using Nanotechnology to Fight Cancer with Laurent Levy Nanobiotix

Laurent Levy, CEO, Nanobiotix talks about using nanoparticles and nanotechnology to destroy cancer cells by bringing a physics perspective to drug development. The Nanobiotix technology has demonstrated improvement in the efficacy of radiation therapy for patients with soft tissue sarcoma, with an intention to expand across oncology, reducing the side effects and potentially reducing duration of the radiation.

14 MIN1 w ago
Comments
Changing the Physics of Cells Using Nanotechnology to Fight Cancer with Laurent Levy Nanobiotix

Leveraging Advanced Machine Learning to Improve Healthcare with Nancy Hornberger ElectrifAi

Nancy Hornberger, EVP, ElectrifAi, worked with IBM & the Watson Group earlier in her career. She brings deep expertise about data to a company that is using advanced machine learning & artificial intelligence to drive profit improvement, increase performance & reduce risk in the health care industry. We talk about the role of ML & Ai in helping to balance system demands & streamlining processes by reducing mundane work of looking at raw data & images so that clinicians can make better diagnostic decisions.

16 MIN2 w ago
Comments
Leveraging Advanced Machine Learning to Improve Healthcare with Nancy Hornberger ElectrifAi

Treating Central Nervous System and Neural System Diseases by Improving Efficacy of Compounds with Dr. Werner Rein Theranexus

Dr. Werner Rein, Chief Medical Officer, Theranexus shines a light on their evolving understanding of central nervous and neurological system diseases, the discovery of the glial system in the brain and the connection between the glial cells and neurons, and the drive to find compound combinations that can be modulated to treat sleep-wake disorder, cognitive decline and chronic pain.

15 MIN2 w ago
Comments
Treating Central Nervous System and Neural System Diseases by Improving Efficacy of Compounds with Dr. Werner Rein Theranexus

Impact of COVID-19 on Breast Cancer Treatment with Dr. Andrea Madrigrano Surgeon Rush University Medical Center

Dr. Andrea Madrigrano is a general surgeon w/expertise in breast cancer at Rush University Medical Center in Chicago.She shines a light on how hospitals have determined the non-essential surgeries in these times of the COVID virus, how women are dealing w/delayed surgeries related to their breast cancer, alternative therapies that are buying some time for women while they wait for restrictions to lift, & opportunity for research comparing results from current innovations with more traditional approaches.

14 MIN2 w ago
Comments
Impact of COVID-19 on Breast Cancer Treatment with Dr. Andrea Madrigrano Surgeon Rush University Medical Center

Using AI to Identify Combinations of Drugs to Fight COVID-19 with Daniel Cohen Pharnext

Daniel Cohen, Founder, Pharnext discusses how the French biopharma company is using its artificial intelligence (AI) driven platform to identify drugs that have already been approved which can be used in combination to fight COVID-19. Dr. Cohen who lead Pharnext as CEO for over a decade has recently left that role to become Chairman of Pharnext's Scientific Advisory Board in order to focus on his true passion--maximizing the potential of Pharnext's Pleotherapy platform.

16 MIN3 w ago
Comments
Using AI to Identify Combinations of Drugs to Fight COVID-19 with Daniel Cohen Pharnext

Pepinemab Antibody Drug in Development for Neurodegenerative Diseases with Maurice Zauderer Vaccinex

Maurice Zauderer, CEO, Vaccinex discusses pepinemab, the antibody drug being developed by Vaccinex for treatment of Huntington's disease, Alzheimer's disease and lung cancer. Maurice also touches on the relationship between neurodegenerative diseases and cancer, and the commonalities that allow for a treatment like pepinemab to have a potential benefit in both therapeutic areas.

15 MIN3 w ago
Comments
Pepinemab Antibody Drug in Development for Neurodegenerative Diseases with Maurice Zauderer Vaccinex

Why Type 2 Diabetes is a Risk Factor for COVID-19 with Dr. John Poothullil

Dr. John Poothullil is an expert on diabetes and author with many books on the subject of diabetes, cancer, and diet. He shares insights about why type 2 diabetes is considered such a high risk factor for COVID-19 and how the coronavirus attacks the body. He also discusses the challenges of identifying the correct antibodies to fight the disease and provides advice for people with type 2 diabetes as well as everyone else about social distancing, diets and exercise in these stressful times.

16 MINAPR 24
Comments
Why Type 2 Diabetes is a Risk Factor for COVID-19 with Dr. John Poothullil
hmly
Welcome to Himalaya Premium